Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.52 Million USD | -65.17% |
| 2022 | 5.93 Million USD | 128.81% |
| 2021 | 7.07 Million USD | 25.98% |
| 2020 | 5.27 Million USD | 2.79% |
| 2019 | 5.46 Million USD | 7.9% |
| 2018 | 5.06 Million USD | 44.74% |
| 2017 | 4.16 Million USD | 177.17% |
| 2016 | 1.53 Million USD | -6.89% |
| 2015 | 1.35 Million USD | 15.65% |
| 2014 | 1.15 Million USD | 175.07% |
| 2013 | 426.03 Thousand USD | 133.81% |
| 2012 | -1.26 Million USD | 2.96% |
| 2011 | -1.29 Million USD | 9.84% |
| 2010 | -1.44 Million USD | -20.57% |
| 2009 | -1.19 Million USD | -247.14% |
| 2008 | -344.13 Thousand USD | -57.1% |
| 2007 | -219.05 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.52 Million USD | -43.58% |
| 2024 Q2 | 1.74 Million USD | 2.63% |
| 2023 FY | - USD | -65.17% |
| 2023 Q2 | 826.88 Thousand USD | -47.2% |
| 2023 Q3 | 445.9 Thousand USD | -46.07% |
| 2023 Q4 | 2.75 Million USD | 518.58% |
| 2023 Q1 | 1.56 Million USD | -70.26% |
| 2022 Q4 | 5.26 Million USD | 558.47% |
| 2022 Q3 | 799.58 Thousand USD | -45.76% |
| 2022 FY | - USD | 128.81% |
| 2022 Q1 | 1.88 Million USD | -12.37% |
| 2022 Q2 | 1.47 Million USD | -21.97% |
| 2021 Q2 | 1.55 Million USD | -22.82% |
| 2021 Q1 | 2.01 Million USD | -6.62% |
| 2021 Q4 | 2.15 Million USD | 60.38% |
| 2021 FY | - USD | 25.98% |
| 2021 Q3 | 1.34 Million USD | -13.64% |
| 2020 Q3 | 1.39 Million USD | 256.06% |
| 2020 FY | - USD | 2.79% |
| 2020 Q2 | 391.23 Thousand USD | -76.58% |
| 2020 Q4 | 2.16 Million USD | 55.06% |
| 2020 Q1 | 1.67 Million USD | -2.24% |
| 2019 Q4 | 1.7 Million USD | 32.75% |
| 2019 Q1 | 1.37 Million USD | 21.71% |
| 2019 FY | - USD | 7.9% |
| 2019 Q2 | 1.09 Million USD | -20.38% |
| 2019 Q3 | 1.28 Million USD | 17.76% |
| 2018 Q1 | 1.37 Million USD | 48.83% |
| 2018 FY | - USD | 44.74% |
| 2018 Q4 | 1.12 Million USD | -6.31% |
| 2018 Q3 | 1.2 Million USD | -11.1% |
| 2018 Q2 | 1.35 Million USD | -1.57% |
| 2017 Q2 | 698.12 Thousand USD | 9.89% |
| 2017 Q1 | 635.27 Thousand USD | -13.71% |
| 2017 FY | - USD | 177.17% |
| 2017 Q4 | 924.59 Thousand USD | -25.43% |
| 2017 Q3 | 1.23 Million USD | 77.6% |
| 2016 Q4 | 736.21 Thousand USD | 386.62% |
| 2016 Q2 | 233.43 Thousand USD | 100.51% |
| 2016 FY | - USD | -6.89% |
| 2016 Q3 | 151.29 Thousand USD | -35.19% |
| 2016 Q1 | 116.42 Thousand USD | -74.02% |
| 2015 FY | - USD | 15.65% |
| 2015 Q4 | 448.21 Thousand USD | 54.85% |
| 2015 Q3 | 289.44 Thousand USD | -25.51% |
| 2015 Q2 | 388.55 Thousand USD | 90.24% |
| 2015 Q1 | 204.24 Thousand USD | -61.89% |
| 2014 Q1 | 124.25 Thousand USD | -65.13% |
| 2014 Q2 | 289.88 Thousand USD | 133.31% |
| 2014 Q3 | 221.75 Thousand USD | -23.5% |
| 2014 Q4 | 536 Thousand USD | 141.72% |
| 2014 FY | - USD | 175.07% |
| 2013 Q1 | -34.02 Thousand USD | -131.81% |
| 2013 Q2 | 69.77 Thousand USD | 305.06% |
| 2013 Q3 | 33.93 Thousand USD | -51.36% |
| 2013 Q4 | 356.34 Thousand USD | 950.0% |
| 2013 FY | - USD | 133.81% |
| 2012 Q4 | 106.95 Thousand USD | 143.96% |
| 2012 FY | - USD | 2.96% |
| 2012 Q2 | -696.17 Thousand USD | -62.82% |
| 2012 Q1 | -427.58 Thousand USD | -84.82% |
| 2012 Q3 | -243.3 Thousand USD | 65.05% |
| 2011 FY | - USD | 9.84% |
| 2011 Q4 | -231.34 Thousand USD | -22.39% |
| 2011 Q2 | -273.28 Thousand USD | 54.82% |
| 2011 Q1 | -604.89 Thousand USD | -20.84% |
| 2011 Q3 | -189.02 Thousand USD | 30.83% |
| 2010 Q4 | -500.57 Thousand USD | -163.2% |
| 2010 FY | - USD | -20.57% |
| 2010 Q2 | -285.44 Thousand USD | 38.47% |
| 2010 Q3 | -190.18 Thousand USD | 33.37% |
| 2010 Q1 | -463.93 Thousand USD | 1.12% |
| 2009 Q2 | -404.75 Thousand USD | -1989.79% |
| 2009 FY | - USD | -247.14% |
| 2009 Q4 | -469.18 Thousand USD | -936.94% |
| 2009 Q3 | -45.24 Thousand USD | 88.82% |
| 2009 Q1 | -19.36 Thousand USD | 78.44% |
| 2008 FY | - USD | -57.1% |
| 2008 Q2 | -229.39 Thousand USD | -1050.42% |
| 2008 Q1 | -19.94 Thousand USD | -239.84% |
| 2008 Q3 | -48.98 Thousand USD | 78.65% |
| 2008 Q4 | -89.84 Thousand USD | -83.42% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | -192.51 Thousand USD | 0.0% |
| 2007 Q3 | -15.62 Thousand USD | 91.88% |
| 2007 Q4 | 14.26 Thousand USD | 191.28% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 2113.061% |
| IR-Med Inc. | -4.89 Million USD | 212.871% |
| Polarean Imaging plc | -11.19 Million USD | 149.322% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -1110.723% |
| Avitar, Inc. | -1.66 Million USD | 431.072% |
| AVITA Medical, Inc. | -39.56 Million USD | 113.955% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 574.366% |
| Össur hf. | 137.38 Million USD | 95.981% |
| Zecotek Photonics Inc. | -3.44 Million USD | 260.409% |
| QHSLab, Inc. | -91.29 Thousand USD | 6148.246% |
| Wellstar International, Inc. | -1.35 Million USD | 507.044% |
| Össur hf. | 137.38 Million USD | 95.981% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 43.508% |
| Escalon Medical Corp. | -58.46 Thousand USD | 9544.972% |
| Aurora Spine Corporation | -454.37 Thousand USD | 1315.205% |
| BrainsWay Ltd. | -2.31 Million USD | 338.928% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 158.87% |
| Vivos Inc. | -2.79 Million USD | 297.685% |
| MicroPort Scientific Corporation | -347.57 Million USD | 101.589% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 2893.058% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 430.923% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 1557.255% |
| Nanomix Corporation | -8.13 Million USD | 167.835% |
| Theraclion SA | -2.05 Million USD | 369.244% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 880.96% |
| Positron Corporation | -1.45 Million USD | 480.238% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 420.673% |
| Lombard Medical, Inc. | -28.06 Million USD | 119.672% |
| ALR Technologies Inc. | -6.4 Million USD | 186.271% |
| Stratec SE | 39.91 Million USD | 86.166% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -5370.042% |
| Heart Tronics, Inc. | -14.85 Million USD | 137.165% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 4769.095% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 141.588% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 160.332% |
| VMS Rehab Systems, Inc. | -68.55 USD | 8054986.944% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 276.635% |
| Ingen Technologies, Inc. | -8639.00 USD | 64015.094% |
| Odyssey Group International, Inc. | -2.13 Million USD | 358.252% |
| United American Healthcare Corporation | -59 Thousand USD | 9458.686% |
| ECGI Holdings, Inc. | -2.99 Million USD | 284.643% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 977.586% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 1174.194% |
| Urologix, Inc. | -6.34 Million USD | 187.037% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 545.522% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 820.87% |
| SS Innovations International, Inc. | -20.37 Million USD | 127.099% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 2578.087% |
| Smith & Nephew plc | 1 Billion USD | 99.449% |
| NIOX Group Plc | 11.07 Million USD | 50.144% |
| Fuse Medical, Inc. | 1.83 Million USD | -200.854% |
| Broncus Holding Corporation | -25.19 Million USD | 121.912% |
| Brain Scientific Inc. | -7.93 Million USD | 169.597% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 158.798% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 30108.832% |